Chronic Liver Disease
Stretching, meditation ‘one of the arrows in a quiver’ to reduce muscle cramps in cirrhosis
Both stretching and meditation reduced cramp severity and improved quality of life among patients with cirrhosis and may be considered as nonpharmacologic interventions when treating nocturnal muscle cramps, according to researchers.
Bariatric surgery associated with lower mortality, health care cost in patients with MASLD
WASHINGTON — Bariatric surgery was associated with improved clinical outcomes and more cost-effective health care resource utilization among patients with metabolic dysfunction-associated steatotic liver disease, according to data.
GLP1s may lower 10-year risk for major adverse outcomes in chronic liver disease, diabetes
Adherence to treatment with glucagon-like peptide-1 receptor agonists may lower the long-term risk for major adverse liver outcomes among patients with chronic liver disease and type 2 diabetes, according to data in Gut.
High daily intake of sugar-sweetened beverages linked to 85% greater risk for liver cancer
Postmenopausal women who consumed at least one sugar-sweetened soft drink per day had significantly higher incidence of liver cancer and chronic liver disease mortality, compared with those who drank no more than three beverages per month.
NAFLD, alcohol-associated liver disease spur rise in global liver cancer deaths
LONDON — Nonalcoholic fatty liver disease and alcohol-associated liver disease are among the main contributors of increased mortality related to chronic liver disease and liver cancer burden, according to research.
Top 10 from ACG: Clostridioides difficile, CRC screening, health disparities
VIDEO: Physicians should be more aware of chronic liver disease treatment guidelines
LAS VEGAS – In this video exclusive, Nancy S. Reau, MD, FAASLD, AGAF, discussed the Liver Health Annual Trends Report, which was launched during a panel discussion hosted by Salix Pharmaceuticals at the ACG Annual Scientific Meeting.
VIDEO: Patient advocate sheds light on ‘urgency’ to treat chronic liver disease
LAS VEGAS – In this video exclusive, Donna Cryer, JD, founder, president and CEO Global Liver Institute, spoke on the launch of the Liver Health Annual Trends Report and its possible impact for patients with chronic liver disease.
Chronic liver disease, alcohol use disorders contribute to mortality, disease burden in COVID-19
Independent risk factors for COVID-19 mortality included chronic liver disease and alcohol use disorders, which also contributed to disease burden in 2020, according to a presenter at the International Liver Congress.